IDEXX Laboratories stock after-hours at EUR 471.50: plus 1.34 percent
Published on 09/29/2026 at 19:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IDEXX Laboratories stock was at EUR 471.50 in after-hours trading on September 29, 2026, at 7:47 p.m. CEST, according to Lang & Schwarz. The price was up EUR 6.25, or 1.34 percent, versus the prior Lang & Schwarz close of EUR 465.25.
Software acquisition announced
On September 16, 2026, IDEXX Laboratories, Inc. announced the acquisition of CoVetAI Inc., a provider of artificial-intelligence-based ambient listening and clinical workflow software for veterinary practices. IDEXX said CoVet will be integrated into its software ecosystem, while the ecosystem will continue to support other ambient scribe solutions and third-party integrations. Financial terms were not disclosed. IDEXX Laboratories
Faecal testing expanded in the United Kingdom
In a September 17, 2026 release, IDEXX said its Faecal Dx antigen testing platform in the United Kingdom had been expanded to detect taeniid tapeworm, including Taenia and Echinococcus species. The company said the United Kingdom panels for IDEXX Reference Laboratories customers included the added detection at no additional cost and that positive results would automatically initiate a complimentary follow-up Echinococcus RealPCR test. IDEXX Laboratories
